Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
— STAROfficial title:
Effects of a Brief Pedometer-based Behavioural Intervention for Individuals With COPD During In-patient Pulmonary Rehabilitation on 6-weeks and 6-months Objectively Measured Physical Activity - A Randomised Controlled Trial
| NCT number | NCT02966561 |
| Other study ID # | 5.011-6.031.115 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | June 2016 |
| Est. completion date | December 2019 |
| Verified date | November 2020 |
| Source | University of Erlangen-Nürnberg |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The STAR-study (STay Active after Rehabilitation) investigates in a randomized controlled trial (RCT) the additional effect of a pedometer-based behavior change intervention (BCI) during in-patient pulmonary rehabilitation (PR) on objectively measured physical activity (PA) 6-weeks and 6-months post PR. The BCI uses the behaviour change techniques a) instruction on how, where and when to perform the behavior, b) prompt goal setting for physical activity, c) prompt self-monitoring of behavior and d) feedback on behavior. The primary outcome of PA will be measured using an accelerometer (Actigraph wGT3X) for a time period of seven days, firstly two weeks before rehabilitation begins (T0 = study phase I) as well as six weeks and six months (T3 and T4) after PR. Additionally to predict PA progression after PR, a complex personal diagnostic, including questionnaires as well as functional assessments, is to be carried out at the start (T1 = start of study phase II) and end of PR (T2). This diagnostic is based on the main ideas of the PA-related health competence model (PARC-model) and especially incorporates physical and psychological personal determinants of PA.
| Status | Completed |
| Enrollment | 418 |
| Est. completion date | December 2019 |
| Est. primary completion date | December 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 80 Years |
| Eligibility | Inclusion Criteria: - Main diagnosis for the Pulmonary Rehabilitation is an International Classification of Diseases-Code J44.- (Other chronic obstructive pulmonary disease) at all 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Classifications A-D and stages 1-4. Exclusion Criteria: - Considerably reduced health status (severe concomitant disease, which will affect the results of the outcome parameters, for example, cancer or severe cardiac, neurological or orthopaedic comorbidities) - Considerable reduction of sight and hearing - Severe psychiatric condition as secondary diagnosis - Lack of ability to speak German |
| Country | Name | City | State |
|---|---|---|---|
| Germany | Bad Reichenhall Clinic, Center for Rehabilitation, Pulmonology and Orthopedics | Bad Reichenhall | Bavaria |
| Lead Sponsor | Collaborator |
|---|---|
| University of Erlangen-Nürnberg | Bad Reichenhall Clinic, Center for Rehabilitation, Pulmonology and Orthopedics, German Statutory Pension Insurance |
Germany,
Geidl W, Carl J, Cassar S, Lehbert N, Mino E, Wittmann M, Wagner R, Schultz K, Pfeifer K. Physical Activity and Sedentary Behaviour Patterns in 326 Persons with COPD before Starting a Pulmonary Rehabilitation: A Cluster Analysis. J Clin Med. 2019 Aug 29;8 — View Citation
Geidl W, Semrau J, Streber R, Lehbert N, Wingart S, Tallner A, Wittmann M, Wagner R, Schultz K, Pfeifer K. Effects of a brief, pedometer-based behavioral intervention for individuals with COPD during inpatient pulmonary rehabilitation on 6-week and 6-month objectively measured physical activity: study protocol for a randomized controlled trial. Trials. 2017 Aug 29;18(1):396. doi: 10.1186/s13063-017-2124-z. — View Citation
Janssens T, Van de Moortel Z, Geidl W, Carl J, Pfeifer K, Lehbert N, Wittmann M, Schultz K, von Leupoldt A. Impact of Disease-Specific Fears on Pulmonary Rehabilitation Trajectories in Patients with COPD. J Clin Med. 2019 Sep 13;8(9). pii: E1460. doi: 10. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Changes in objectively measured physical activity | On each measurement occasion physical activity is going to be measured on seven consecutive days with a 3-axis accelerometer (Actigraph wGT3X-BT) | 2 weeks before pulmonary rehabilitation (T0), 6 weeks after pulmonary rehabilitation (T3) and 6 months after pulmonary rehabilitation (T4) | |
| Secondary | Body-mass index, obstruction, dyspnea, and exercise (BODE index) | Questionnaire: Including body-mass index, airflow obstruction (FEV1), dyspnea (MRC-dyspnea scale) and exercise capacity (6-Min-Walk-Test) | During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2) | |
| Secondary | Baseline dyspnea index (BDI) and transitional dyspnea Index (TDI) | Questionnaire: Baseline and transitional dyspnea | During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2); 6 weeks after pulmonary rehabilitation (T3) and 6 months after pulmonary rehabilitation (T4) | |
| Secondary | Dyspnea, cough, sputum, pain | Questionnaire: Numeric Rating Scales (self-developed) | During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2); 6 weeks after pulmonary rehabilitation (T3) and 6 months after pulmonary rehabilitation (T4) | |
| Secondary | COPD-Anxiety Questionnaire (CAF) | Questionnaire: COPD specific anxiety | During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2); 6 months after pulmonary rehabilitation (T4) | |
| Secondary | Patient Health Questionnaire (PHQ-D9) | Questionnaire: Depression | During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2); 6 months after pulmonary rehabilitation (T4) | |
| Secondary | St. Georges Respiratory Questionnaire (SGRQ) | Questionnaire: Health-related quality of life | 2 weeks before pulmonary rehabilitation (T0); During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2); 6 weeks (T3) and 6 months (T4) after pulmonary rehabilitation | |
| Secondary | COPD Assessment Test (CAT) | Questionnaire: Impact of COPD on health status | 2 weeks before pulmonary rehabilitation (T0); During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2); 6 weeks (T3) and 6 months (T4) after pulmonary rehabilitation | |
| Secondary | Control competence for physical training, physical activity-specific mood regulation and self-control, physical activity-related self efficacy, psychological need satisfaction in exercise | Questionnaire: Facets of physical activity-related health competence (PARC-Model) | During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2) | |
| Secondary | Single-target Implicit Association Test (ST-IAT) | Computer-based test: Automatic affect towards physical activity | During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2) | |
| Secondary | Stage of change algorithm for physical activity | Questionnaire: Adapted based on the transtheoretical model (TTM) | During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2) | |
| Secondary | Sport- and Movement-related Self-Concordance (SSK) | Questionnaire: Self-concordance/ quality of motivation | During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2) | |
| Secondary | Affective explicit attitudes towards performing sports activities | Questionnaire: Explicit cognitive and affective attitudes toward sports activities | During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2) | |
| Secondary | Breathlessness Catastrophizing | Questionnaire: Breathlessness Catastrophizing Scale | During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2); 6 months after pulmonary rehabilitation (T4) | |
| Secondary | Intolerance of Uncertainty Scale (UI-18) | Questionnaire: Disposition to react negative on uncertain situations | During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2); 6 months after pulmonary rehabilitation (T4) | |
| Secondary | Life Orientation Test-Revised (LOT-R) | Questionnaire: Dispositional optimism | During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2); 6 months after pulmonary rehabilitation (T4) | |
| Secondary | 6 Minute Walking Test | Functional Test | During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2) | |
| Secondary | Satisfaction with the pulmonary rehabilitation | Questionnaire (self-developed): Satisfaction with interventional components of the pulmonary rehabilitation | During the third and thus last week of pulmonary rehabilitation (T2) | |
| Secondary | Demographic characteristics | Questionnaire: sex, age, height, marital status, education, weight, self-reported work status | During the first week of pulmonary rehabilitation (T1) | |
| Secondary | Social medical characteristics | Initial physical examination including diagnosis, medication, smoking status, lung function | During the first week of pulmonary rehabilitation (T1) | |
| Secondary | Sick days and use of health care services | Questionnaire: Days of incapacity to work, days in hospital, COPD-related emergency treatment | 6 weeks after pulmonary rehabilitation (T3); 6 months after pulmonary rehabilitation (T4) | |
| Secondary | Fear avoidance COPD | Questionnaire: COPD disease-related fears | During the first week of pulmonary rehabilitation (T1); During the third and thus last week of pulmonary rehabilitation (T2); 6 months after pulmonary rehabilitation (T4) | |
| Secondary | Self-reported physical activity | Questionnaire: Physical Activity, Exercise, and Sport | 2 weeks before pulmonary rehabilitation (T0), 6 weeks after pulmonary rehabilitation (T3) and 6 months after pulmonary rehabilitation (T4) |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03282019 -
Study of Long-term HFNC for COPD Patients With HOT
|
N/A | |
| Completed |
NCT05573464 -
A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With the Hydrofluoroolefin Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
|
Phase 3 | |
| Recruiting |
NCT06040086 -
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
|
Phase 3 | |
| Not yet recruiting |
NCT06376994 -
Multi-Center Clean Air Randomized Controlled Trial in COPD
|
Phase 3 | |
| Completed |
NCT02797392 -
Feasibility of a Preventive Program Against Lifestyle Related Diseases
|
N/A | |
| Completed |
NCT02728674 -
Management of Patients With Respiratory Symptoms in Sweden
|
N/A | |
| Completed |
NCT02926534 -
Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan
|
N/A | |
| Recruiting |
NCT02415478 -
Bronchioscopic Lung Volume Reduction (BLVR)
|
N/A | |
| Completed |
NCT02512510 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT02459080 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT03487406 -
Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)
|
Phase 2 | |
| Completed |
NCT02774226 -
Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
| Completed |
NCT02518139 -
A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT01893476 -
A Pragmatic Cluster Trial of a Tailored Intervention to Improve COPD Management
|
N/A | |
| Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
| Withdrawn |
NCT01908933 -
Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema
|
Phase 3 | |
| Completed |
NCT01908140 -
Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT01701869 -
Microbiology & Immunology of the Chronically-inflamed Airway
|
N/A | |
| Recruiting |
NCT02527486 -
Seoul National University Airway Registry
|
N/A | |
| Withdrawn |
NCT01377428 -
Efficacy of Indacaterol 150 µg Versus Formoterol
|
Phase 4 |